Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
Clinical trial NCT03050151 · COMPLETED
Trial details
- NCT number
- NCT03050151
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2017-11-14
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.